兩連板的合鍛智能(603011.SH):口罩業務暫不具備商業化的條件
格隆匯3月9日丨連續2個漲停的合鍛智能(603011.SH)發佈公告稱,經核查,近期存在可能或已經對公司股票交易價格產生影響的媒體報道或市場傳聞,主要涉及口罩等熱點概念事項。截至目前,公司尚未取得檢驗檢測結果合格的相關報告,並且公司經營範圍未變更完畢,也未取得醫療器械等業務的許可證書,口罩業務暫不具備商業化的條件。綜合考慮以上因素,預計短期內相關業務收入不超過公司最近一個會計年度經審計營業收入的10%,對公司營業收入、利潤增長沒有實質或重大影響。相關業務後續進展若達到相關信息披露標準,公司將及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.